EADV funded
Behçet’s disease (BD) is a chronic, relapsing multisystemic vasculitis that typically affects individuals in their 30s and 40s, leading to significant morbidity. Its pathogenesis remains enigmatic, shaped by complex genetic, environmental, autoimmune, and autoinflammatory factors.

EADV funded
The SSKAPP project promotes skin disease and STI education among migrants in Malta and Lebanon, using teledermatology and outreach clinics. It served over 3,200 migrants in Malta and diagnosed 598 cases in Lebanon, while training healthcare providers and supporting refugee care.

EADV Press Release
Innovative research has unveiled promising advancements in melanoma detection, which could significantly enhance diagnosis and prognosis by identifying the disease at its earliest, most treatable stages.

EADV Press Release
Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin lesions.

EADV Press Release
Novel research has identified key molecular targets that could significantly enhance the healing of both acute and chronic wounds.

EADV Press Release
A pioneering study demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.

Mohs micrographic surgery (MMS) is the gold standard for basal and squamous cell carcinomas and is increasingly used for non-keratinocytic tumors, including melanomas like lentigo maligna melanoma (LMM) and melanoma in situ (MIS). MMS offers precise cancer removal, but its use for deeper melanomas is still controversial and requires more research.

Histology is the gold standard for melanoma diagnosis, but excising all suspicious lesions is costly. Imaging methods like RCM and LC-OCT are less invasive but expensive, limiting their use. Dermoscopy, however, is affordable and effective, improving diagnosis while reducing unnecessary excisions. This lecture uses images to teach key dermoscopic features of melanocytic lesions and melanoma, covering common pitfalls and special areas like the face and mucosae.

Pediatric cutaneous melanoma is rare, comprising 1% of childhood cancers. It often differs from adult cases, sometimes linked to large congenital nevi. Its rarity and unique traits complicate diagnosis and treatment, emphasizing the need for more research to improve outcomes.

Nail psoriasis and lichen planus are chronic conditions affecting nails and quality of life. Psoriasis shows pitting and onycholysis, possibly needing rheumatologist referral for arthritis. Lichen planus causes ridging and potential permanent damage, requiring early treatment. Treatments include topical and systemic therapies, with future options like JAK inhibitors.

Psoriasis treatments now include biologics targeting TNF-α, IL-17, and IL-23, but patient response varies. Some patients do not respond or lose response, while others achieve near-complete skin clearance, allowing dose reduction. Clinicians are optimizing doses empirically and investigating this for newer biologics. Therapeutic drug monitoring (TDM) measures drug levels and anti-drug antibodies, helping guide treatment based on exposure-response relationships, which have been identified for newer biologics.

Psoriasis affects 125 million people globally, with variations in symptoms and treatment based on skin type, age, gender, race, and ethnicity. Education on these differences can improve care and reduce stigma. Psoriatic arthritis is more severe in darker-skinned individuals. Genetic and environmental factors influence the disease’s severity and should be considered in future research.